Prevention of bone loss in kidney graft recipients

被引：15

作者：

Kovac, D ^{[1
]}

Lindic, J ^{[1
]}

Kandus, A ^{[1
]}

Bren, AF ^{[1
]}

机构：

[1] Univ Med Ctr, Dept Nephrol, Ljubljana 1525, Slovenia

来源：

TRANSPLANTATION PROCEEDINGS | 2001年 / 33卷 / 1-2期

关键词：

D O I：

10.1016/S0041-1345(00)02464-7

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：1144 / 1145

页数：2

共 9 条

[1] Hypercalcemia and hyperparathyroidism after renal transplantation [J].

Apaydin, S ;

Sariyar, M ;

Erek, E ;

Ataman, R ;

Yigitbas, R ;

Hamzaoglu, I ;

Serdengecti, K ;

Ülkü, U .

NEPHRON, 1999, 81 (03) :364-365

[2] Pamidronate therapy as prevention of bone loss following renal transplantation [J].

Fan, SLS ;

Almond, MK ;

Ball, E ;

Evans, K ;

Cunningham, J .

KIDNEY INTERNATIONAL, 2000, 57 (02) :684-690

[3] Treatment of osteopenia and osteoporosis after kidney transplantation [J].

Grotz, WH ;

Rump, LC ;

Niessen, A ;

Schmidt-Gayk, H ;

Reichelt, A ;

Kirste, G ;

Olschewski, M ;

Schollmeyer, PJ .

TRANSPLANTATION, 1998, 66 (08) :1004-1008

[4] RAPID LOSS OF VERTEBRAL MINERAL DENSITY AFTER RENAL-TRANSPLANTATION [J].

JULIAN, BA ;

LASKOW, DA ;

DUBOVSKY, J ;

DUBOVSKY, EV ;

CURTIS, JJ ;

QUARLES, LD .

NEW ENGLAND JOURNAL OF MEDICINE, 1991, 325 (08) :544-550

[5]

Parker C. R., 1999, Calcified Tissue International, V64, pS48

[6] Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis [J].

Saag, KG ;

Emkey, R ;

Schnitzer, TJ ;

Brown, JP ;

Hawkins, F ;

Goemaere, S ;

Thamsborg, G ;

Liberman, UA ;

Delmas, PD ;

Malice, MP ;

Czachur, M ;

Daifotis, AG .

NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (05) :292-299

[7]

Stendig-Lindberg Gustawa, 1993, Magnesium Research, V6, P155

[8]

Talalaj M, 1996, TRANSPL P, V28, P3485

[9] FACTORS INFLUENCING VERTEBRAL BONE-DENSITY AFTER RENAL-TRANSPLANTATION [J].

WOLPAW, T ;

DEAL, CL ;

FLEMINGBROOKS, S ;

BARTUCCI, MR ;

SCHULAK, JA ;

HRICIK, DE .

TRANSPLANTATION, 1994, 58 (11) :1186-1189

← 1 →